Nicardipine vs Esmolol Craniotomy Emergence

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Brain Tumors
Interventions
DRUG

Nicardipine

DRUG

Esmolol

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01951950 - Nicardipine vs Esmolol Craniotomy Emergence | Biotech Hunter | Biotech Hunter